Prognostic Factors in Patients Treated with Second-Line Chemotherapy for Advanced Gastric Cancer: Results from the Randomized Prospective Phase III FFCD-0307 Trial
Gastric cancer(2018)
Abstract
The aim of this study was to determine prognostic factors in patients treated with second-line therapy (L2) for locally advanced or metastatic gastric and gastro-esophageal junction (GEJ) adenocarcinoma in a randomized phase III study with predefined L2.
MoreTranslated text
Key words
Gastric neoplasm,Survival,Prognosis,Second-line chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined